330: How a Trump presidency could affect the FDA, the biotech industry, and its stocks

To dig into how the election results could affect all things biopharma, we brought on three guests for this episode: Lizzy Lawrence, STAT’s FDA reporter, Baird analyst Brian Skorney, and longtime biotech executive Daphne Zohar.

Episode metadata supplied by the publisher feed · Published Nov 7, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

330: How a Trump presidency could affect the FDA, the biotech industry, and its stocks

0:00 39:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 39 minutes long.

When was this The Readout Loud episode published?

This episode was published on November 7, 2024.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!